维普中文期刊产品整合服务
6篇 您的检索式:作者名="Barbara CS"
    题名 作者 年代 出处 被引量
1Magnet Recognition for Nursing Excellence-Is your Organization There Yet 显示文摘Sandra KW Barbara CS Elizabeth H 2006Rehabilitation Nursing2006,31,2:1
2Old and new uses ofsurfactant显示文摘Gizzi C Papoff P Barbara CS 2010J Matem Fetal Neonat Med2010,23,3:1
3Integrins in angiogenesis and lymphangiogenesis 显示文摘Christie JA Barbara CS Judith AV 2008Nat Rev Cancer2008,8,8:1
4Risk factors for renal allograft survival from pediatric cadaver donors: an analysis of united network for organ sharing data 显示文摘Barbara AB Maureen MA Wida CS 2001Transplantation2001,72,2:1
5Primary sutureless repair for infants with mixed total anomalous pulmonary venous drainage显示文摘Osami H Cori RA Barbara CS 2010Ann Thorac Surg2010,90,:1
6Immunosuppressive treatment and radiotherapy in kidney transplant patients:A systematic review显示文摘BACKGROUND Immunosuppression(IS)therapy may contribute to cancer development.Some authors have proposed to reduce immunosuppression drugs dose in case of viral infections,in immunosuppression-related diseases,and in patients undergoing radiotherapy.The present analysis reports the results of a systematic review on kidney transplant recipients undergoing immunosuppression and radiotherapy.AIM To define if it is necessary reduce immunosuppression drugs during radiotherapy.METHODS The literature search was based on three electronic databases(Pubmed,Scopus,and Web of Science)using selected keywords linked through the'AND'and'OR'Boolean operators to build specific strings for each electronic search engine.Two researchers independently screened the citations,and disagreement was resolved by discussion or through the intervention of a third author.The review was conducted and reported according to the PRISMA statement.Extracted data were narratively synthesized,and,where possible,frequencies,percentages,and ranges were calculated.RESULTS The literature search resulted in 147 citations.After abstracts screening,21 records were selected for full-text evaluation.Fifteen of these were excluded,leaving six papers considered suitable for analysis.There is still no clear evidence that withdrawing antimetabolites and/or calcineurin inhibitors and/or mammalian target of rapamycin-inhibitors,as opposed to continuing maintenance IS,improves patient survival in kidney transplant recipients with cancer undergoing radiotherapy.Only few retrospective studies on small cancer patient cohorts are available in this setting,but without comparison of different immunosuppression treatments.Even where immunosuppression therapy was described,patient survival seemed to be correlated only with cancer stage and type.CONCLUSION The results of this systematic review do not support the reduction of immunosuppression dose in patients undergoing radiotherapy.Valentina Lancellotta Andrea D'Aviero Bruno Fionda Calogero Casà Ilaria Esposito Francesco Preziosi Anna Acampora Fabio Marazzi György Kovács Barbara Alicja Jereczek-Fossa Alessio Giuseppe Morganti Vincenzo Valentini Maria Antonietta Gambacorta Jacopo Romagnoli Luca Tagliaferri 2022World Journal of Radiology2022,14,3:0
返回顶部 每页显示:
共1页 首页 上一页 第1页 下一页 末页 /1 跳转

网站首页 | 关于我们 | 联系我们 | 产品服务 | 客服中心 | 广告服务 | 版权声明 | 网站联盟 | 友情链接 | 售卡网点

版权所有© 渝B2-20050021-1 渝公网安备 50019002500403号 违法和不良信息举报中心

互联网出版许可证 新出网证(渝)字10号 全国400电话 - 免长途话费